Immunology
2 drugs are in development for Systemic Lupus Erythematosus.
- Companies
- 2
- Clinical trials
- 66
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Systemic Lupus Erythematosus pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| dnth212 | Dianthus Therapeutics, Inc. /DE/ (DNTH) |
Phase 2(1)
| Drug | Company |
|---|---|
| alpn-101 | ALPINE IMMUNE SCIENCES, INC. (ALPN) |
About this indication
Systemic Lupus Erythematosus context
Immunology·MeSH: Lupus Erythematosus, Systemic (D008180)
Also known as: Lupus Erythematosus Disseminatus
Prevalence
72.0 / 100K
Incidence
5.1 / 100K/yr
Frequently asked questions
How many drugs are in development for Systemic Lupus Erythematosus?
BioSniper tracks 2 drugs in development for Systemic Lupus Erythematosus across 2 companies.
How many clinical trials target Systemic Lupus Erythematosus?
There are 66 clinical trials targeting Systemic Lupus Erythematosus tracked by BioSniper.
What is the prevalence of Systemic Lupus Erythematosus?
The estimated prevalence of Systemic Lupus Erythematosus is approximately 72.0 per 100,000 population.